@article{47fcd45f9a7a4f0380c253230e6a470e,
title = "Preface to BBA issue devoted to fibrosis",
author = "Friedman, {Scott L.}",
note = "Funding Information: Dr. Scott L. Friedman is the Chief of the Division of Liver Diseases and Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai. Dr. Friedman was the first to establish the hepatic stellate cell as the key cell type responsible for fibrosis production in liver while a fellow in the laboratory of D. Montgomery Bissell at UCSF. Dr. Friedman's work has contributed significantly to the growth of the fibrosis field, which is now beginning to realize its translational and therapeutic potential. Dr. Friedman's research has been continuously funded by the NIH since 1985, and his laboratory also frequently performs studies to test novel antifibrotic compounds in pre-clinical models, supported by the biotechnology and pharmaceutical industries. ",
year = "2013",
month = jul,
doi = "10.1016/j.bbadis.2013.03.003",
language = "English",
volume = "1832",
pages = "865",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "7",
}